ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #716Top JournalHybrid

Neuropsychopharmacology

Acronym:npp
•
Abbreviation (ISO):NEUROPSYCHOPHARMACOL
•
Identifier (ISSN):0893-133X(Print)/1740-634X(Online)
•
Publisher:Springer Nature
Clarivate IF (2026)
7.6↑ +0.5
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Neuropsychopharmacology

WoS Q1
469116.5420187.1620196.7520207.8520218.2920227.620236.620247.120257.62026
Annual Impact Factor Metric
Current (2026):7.6
Scopus SJR & RankScopus Q1
2.988
#716

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
269

269 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate1.5%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
234articles/year
50.27% Gold OA•87.82% Original Research

Aims & Scope

Neuropsychopharmacology is an international scientific journal and the official publication of the American College of Neuropsychopharmacology. The journal focuses on clinical and basic science contributions that advance our understanding of the brain and behavior.

Topics Covered (Recognized by AI)
Psychology97%Medicine94.8%Biology94.8%Internal medicine83.8%Neuroscience82.9%Psychiatry73.3%Chemistry71.1%Biochemistry69%Endocrinology68.6%Genetics67.1%Receptor54.6%Pharmacology38.5%Dopamine28.1%Cognition25.8%Computer science23.3%Pathology22.9%Clinical psychology20.6%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

NEUROSCIENCES

Q1
Rank28/330
IndexSCIE
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q1
Rank26/356
IndexSCIE
JCRSCIE2026

PSYCHIATRY

Q1
Rank16/293
IndexSCIE
JCISCIE2026

NEUROSCIENCES

Q1
Rank29/330
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q1
Rank23/356
IndexSCIE
JCISCIE2026

PSYCHIATRY

Q1
Rank22/293
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF7.6
Articles / Year260
Total Citations199
2025
IF7.1
Articles / Year260
Total Citations1,008
2024
IF6.6
Articles / Year262
Total Citations2,574
2023
IF7.6
Articles / Year301
Total Citations5,501
2022
IF8.294
Articles / Year271
Total Citations7,123

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #716Scopus Q1SCImago Profile
Scopus Coverage:1987-2026
Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q1
2.988

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
6.23

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,989 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations5,844
3-Year Documents821
Citable Documents671

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate45.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

PharmacologyQ1
Psychiatry and Mental HealthQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 1.5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
1区 (Zone 1)Medicine
Minor Category (Specific Field):
2区NEUROSCIENCES
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Neuropsychopharmacology (acronym: npp, abbr: NEUROPSYCHOPHARMACOL, ISSN: 0893-133X) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer Nature in England since 1993. The periodical holds a Journal Impact Factor (JIF) of 7.60, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 2.988 (Q1), an H-index of 269.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 234 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,989 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer Nature
Publication Language
English
Frequency
Monthly
Founding Year
1993
Indexing & Databases
SCIEScopusPubMed
Editorial Address
NATURE PUBLISHING GROUP, MACMILLAN BUILDING, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: b14ac268-0902-4ed1-a569-402f6302390e
Database Updated: 2026-10-01